Brain Shuttle Peptides: Development and Applications: Volume 105
Academic Press
Published on 8. June 2026
Book
Hardback
258 pages
978-0-443-41547-0 (ISBN)
Description
Advances in Pharmacology, Volume 105, a new volume in this ongoing series, highlights new advances in the field, with this new volume presenting interesting chapters on a variety of topics, including Introduction to brain shuttle peptides, In silico optimization of brain shuttle properties for passive diffusion, Shuttles derived from natural proteins, Shuttles derived from phage display, Chemically enhanced brain shuttle peptides, Brain delivery of gold nanoparticles, Brain delivery of lipid nanoparticles, Brain delivery of therapeutic proteins, In vitro BBB models for the study of brain shuttle transport, Physiological strategies for delivery across the BBB, and Polymeric Nanoparticles.
More details
Series
Language
English
Place of publication
San Diego
United States
Publishing group
Elsevier Science Publishing Co Inc
Target group
Professional and scholarly
Dimensions
Height: 229 mm
Width: 152 mm
Weight
450 gr
ISBN-13
978-0-443-41547-0 (9780443415470)
Copyright in bibliographic data is held by Nielsen Book Services Limited or its licensors: all rights reserved.
Schweitzer Classification
Other editions
Additional editions

E-Book
06/2026
Elsevier
€183.00
Available for download
Persons
Barbara Slusher is a Professor of Neurology (primary), Pharmacology and Molecular Sciences, Psychiatry, Neuroscience, Medicine, and Oncology at Johns Hopkins School of Medicine. She also serves as the Director of the Johns Hopkins Drug Discovery, the Vice Director of the Pedersen Brain Science Institute, and the Co-Director of the Johns Hopkins Center for the Advancement of HIV Neurotherapeutics (JH CAHN). She has published over 300 scientific articles and is an inventor on over100 patents and applications. Before joining Johns Hopkins, she spent 18 years in the pharmaceutical industry, including several years at the level of Senior Vice President of Research and Translational Development. She has extensive experience in drug discovery through early clinical development and was involved in the successful development, launch and/or post marketing support of several FDA-approved medicines. In 2010, she joined Johns Hopkins to lead the largest drug discovery program on campus with a veteran team of over 25 medicinal chemists, assay developers, pharmacologists, toxicologists, and pharmacokinetics/drug metabolism experts. The team identifies novel drug targets and translates them into new drug therapies for clinical development. Since joining JHU, she has co-founded four new companies which have amassed over $150M in financing and has partnered four new drug discovery programs with Pharma. She also founded the first International Consortium of Academic Drug Discovery Centers (http://addconsortium.org/) with over 150 university-led translational centers and 1500 members to bring together this growing community. Dr. Slusher received her undergraduate degree from Dickinson College where she graduated valedictorian, majoring in Chemistry. She received her Ph.D. in Pharmacology and Molecular Sciences from the Johns Hopkins School of Medicine while simultaneously earning her Master's degree in Administrative Science from the Johns Hopkins Carey School of Business (formerly School of Continuing Studies). Diane Peters is an Assistant Professor of Pharmacology and Molecular Sciences at the Johns Hopkins School of Medicine. She received her BA in Chemistry, with honors, from Wellesley College, followed by pursuit of a PhD in Pharmacology and Experimental Therapeutics from the Tufts University School of Medicine. Subsequently, she earned an MS in laboratory animal medicine as well as a doctorate of veterinary medicine, both granted by the Tufts University School of Veterinary Medicine. Dr. Peters performed her post-graduate fellowship training in laboratory animal medicine at the Johns Hopkins University School of Medicine, where she further refined research expertise in comparative medicine, translational drug discovery, and animal pharmacology/toxicology.
Volume editor
Series Editor
Content
1. Introduction to brain shuttle peptides
Benjami Oller-Salvia and Macarena Sanchez Navarro
2. In silico optimization of brain shuttle properties for passive diffusion
Daniela Kalafatovic, Patrizia Jankovic, Marko Njirjak, Nikolina Mohovic and Ena Drazic
3. Shuttles derived from natural proteins
Toni Todorovski, Wadih Arap and Andrej Nikolic
4. Shuttles derived from phage display
Renata Pasqualini
5. Chemically enhanced brain shuttle peptides
Cristina Diaz
6. Brain delivery of gold nanoparticles
Marcelo Kogan
7. Brain delivery of lipid nanoparticles
Ronny Vargas-Monge, Noelia Martinez-Martinez, Laura Carrera-Rodriguez, Carlos Sune and Marc Sune-Pou
8. Brain delivery of therapeutic proteins
Marina Plaza-Garrido
9. In vitro BBB models for the study of brain shuttle transport
Fuzsina Walter
10. Physiological strategies for delivery across the BBB
Daniel Gonzalez Carter
11. Polymeric Nanoparticles
Elena Sanchez Lopez
Benjami Oller-Salvia and Macarena Sanchez Navarro
2. In silico optimization of brain shuttle properties for passive diffusion
Daniela Kalafatovic, Patrizia Jankovic, Marko Njirjak, Nikolina Mohovic and Ena Drazic
3. Shuttles derived from natural proteins
Toni Todorovski, Wadih Arap and Andrej Nikolic
4. Shuttles derived from phage display
Renata Pasqualini
5. Chemically enhanced brain shuttle peptides
Cristina Diaz
6. Brain delivery of gold nanoparticles
Marcelo Kogan
7. Brain delivery of lipid nanoparticles
Ronny Vargas-Monge, Noelia Martinez-Martinez, Laura Carrera-Rodriguez, Carlos Sune and Marc Sune-Pou
8. Brain delivery of therapeutic proteins
Marina Plaza-Garrido
9. In vitro BBB models for the study of brain shuttle transport
Fuzsina Walter
10. Physiological strategies for delivery across the BBB
Daniel Gonzalez Carter
11. Polymeric Nanoparticles
Elena Sanchez Lopez